openPR Logo

Press Releases from DelveInsight Business Research LLP (5019 total)

Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Therapeutics Assessme …

DelveInsight's, "Chronic Inflammatory Demyelinating Polyneuropathy Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Chronic Inflammatory Demyelinating Polyneuropathy pipeline

Pancreatic Ductal Adenocarcinoma Pipeline Therapeutics Assessment Report 2024 (U …

DelveInsight's, "Pancreatic Ductal Adenocarcinoma Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Pancreatic Ductal Adenocarcinoma pipeline landscape. It covers

Paroxysmal Nocturnal Hemoglobinuria Pipeline Therapeutics Assessmsent Report 202 …

DelveInsight's, "Paroxysmal Nocturnal Haemoglobinuria Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Paroxysmal Nocturnal Haemoglobinuria pipeline landscape. It

Chronic Pulmonary Hypertension Market Size in the 7MM was ~USD 28,290 million in …

DelveInsight's "Chronic Pulmonary Hypertension Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the

Chronic Lower Back Pain Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Chronic Lower Back Pain Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chronic Lower Back Pain pipeline

Diabetic Neuropathy Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Diabetic Neuropathy Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Diabetic Neuropathy pipeline landscape. It covers the

Epidermolysis Bullosa Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Epidermolysis Bullosa Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the

Dup15q Syndrome Therapeutics Market Size in the 7MM is expected to grow by 2034, …

DelveInsight's "Dup15q Syndrome Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Dup15q Syndrome, historical and forecasted epidemiology as

Alopecia Areata Therapeutics Market Size in the 7MM is expected to grow by 2034, …

DelveInsight's "Alopecia Areata Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Alopecia

Allergic Rhinitis Therapeutics Market Size in the 7MM is expected to grow by 203 …

DelveInsight's "Allergic Rhinitis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Allergic

Progressive Multifocal Leukoencephalopathy Therapeutics Market Size in the 7MM i …

DelveInsight's "Progressive Multifocal Leukoencephalopathy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Progressive Multifocal Leukoencephalopathy, historical and forecasted epidemiology,

Age-Related Macular Degeneration Therapeutics Market Size in the 7MM is expected …

DelveInsight's 'Age-related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034' report deliver an in-depth understanding of the Age-related Macular Degeneration, historical and forecasted epidemiology as

Burn Pain Market to Show a Rise During the Study Period | MediWound Germany GmbH …

DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as

Biopsy Devices Pipeline Insight and Competitive Landscape 2023 | Biopsy Devices …

DelveInsight's "Biopsy Devices - Pipeline Insight and Competitive Landscape 2023," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the biopsy devices

Major Depressive Disorder Clinical Trials | A Drug Pipeline Analysis Report 2024 …

United States, Nevada, Las Vegas, DelveInsight's 'Major Depressive Disorder Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Major Depressive Disorder

Chronic Lower Back Pain Clinical Trials | A Drug Pipeline Analysis Report 2024 | …

United States, Nevada, Las Vegas, DelveInsight's 'Chronic Lower Back Pain Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Chronic Lower

Amyotrophic Lateral Sclerosis Clinical Trials | A Drug Pipeline Analysis Report …

United States, Nevada, Las Vegas, DelveInsight's 'Amyotrophic Lateral Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Amyotrophic Lateral Sclerosis

Prader Willi Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Prader-Willi Syndrome Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in Prader-Willi Syndrome pipeline landscape. It covers the

Prosthetic Joint Infections Pipeline Therapeutics Assessment Report 2024 (Update …

DelveInsight's, "Prosthetic Joint Infections Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Prosthetic Joint Infections pipeline landscape. It

Lamellar Icthyosis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Lamellar Icthyosis Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Lamellar Icthyosis pipeline landscape. It covers the

Influenza Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Influenza Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Influenza pipeline landscape. It covers the Influenza pipeline

Gastrointestinal Stromal Tumor Pipeline Therapeutics Assessment Report 2024 (Upd …

DelveInsight's, "Gastrointestinal Stromal Tumors Pipeline Insight 2024" report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST) pipeline landscape.

Lipodystrophy Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Lipodystrophy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Lipodystrophy pipeline landscape. It covers the pipeline drug

Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …

DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It

Axial Spondyloarthritis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Axial Spondyloarthritis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Axial Spondyloarthritis pipeline landscape. It covers the

Blastic Plasmacytoid Dendritic Neoplasm Pipeline Therapeutics Assessment Report …

DelveInsight's, "Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Malignancy Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Blastic Plasmacytoid

Bronchiectasis Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Bronchiectasis Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchiectasis pipeline landscape. It covers the pipeline drug

Scars Clinical Trials | A Drug Pipeline Analysis Report 2024 | First String Rese …

United States, Nevada, Las Vegas, DelveInsight's 'Scars Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Scars therapies in various stages

Schizophrenia Clinical Trials | A Drug Pipeline Analysis Report 2024 | Otsuka Ph …

DelveInsight's 'Schizophrenia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Schizophrenia therapies in various stages of clinical development, major pharmaceutical

Sciatica Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sciatica Clini …

United States, Nevada, Las Vegas, DelveInsight's 'Sciatica Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sciatica therapies in various stages

Sepsis Clinical Trials | A Drug Pipeline Analysis Report 2024 | SciClone Pharmac …

DelveInsight's 'Sepsis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sepsis therapies in various stages of clinical development, major pharmaceutical

Seborrhoeic Dermatitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | …

DelveInsight's 'Seborrhoeic Dermatitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Seborrhoeic Dermatitis therapies in various stages of clinical development,

Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analy …

DelveInsight's 'Secondary Progressive Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Secondary Progressive Multiple Sclerosis therapies in various

Sensorineural Hearing Loss Clinical Trials | A Drug Pipeline Analysis Report 202 …

DelveInsight's 'Sensorineural Hearing Loss Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sensorineural Hearing Loss therapies in various stages of

Raynaud's Disease Clinical Trials, Key Companies, Emerging Therapies | A Drug Pi …

DelveInsight's 'Raynaud's Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Raynaud's Disease therapies in various stages of clinical development,

Ulcerative Colitis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Oppi …

DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of clinical development,

Acute Kidney Injury Clinical Trials | A Drug Pipeline Analysis Report 2024 | GUA …

DelveInsight's 'Acute Kidney Injury Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Acute Kidney Injury therapies in various stages of

Burns Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Burns Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Burns pipeline landscape. It covers the pipeline drug

Cancer Cachexia Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Cancer Cachexia Pipeline Insight 2024" report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Cancer Cachexia pipeline landscape. It covers the

Dementia with Diabetes Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Dementia with Diabetes Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Dementia with Diabetes pipeline landscape. It

Granulomatosis with Polyangiitis Pipeline Therapeutics Assessment Report 2024 (U …

DelveInsight's, "Granulomatosis with Polyangiitis Pipeline Insight 2024" report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Granulomatosis with Polyangiitis pipeline landscape. It

Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the

Graft Versus Host Disease Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Graft versus host disease Pipeline Insight 2024" report provides comprehensive insights about 60+ GvHD companies and 65+ pipeline drugs in Graft versus host disease

Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma

Dry Age-related Macular Degeneration Pipeline Therapeutics Assessment Report 202 …

DelveInsight's, "Dry Age-related Macular Degeneration Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration

Diabetic Peripheral Neuropathy Pipeline Therapeutics Assessment Report 2024 (Upd …

DelveInsight's, "Diabetic Peripheral Neuropathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Diabetic Peripheral Neuropathy pipeline landscape. It

Angelman Syndrome Treatment Market Size is expected to grow by 2034, estimates D …

Angelman Syndrome Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of

Peripheral Arterial Disease Pipeline Therapeutics Assessment Report 2024 (Update …

DelveInsight's, "Peripheral Arterial Disease Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Peripheral Arterial Disease pipeline landscape. It

Epilepsy Pipeline Therapeutics Assessment Report 2024 (Updated)

DelveInsight's, "Epilepsy Pipeline Insight 2024" report provides comprehensive insights about 85+ companies and 90+ pipeline drugs in Epilepsy pipeline landscape. It covers the pipeline drug

Diffuse Large B-cell Lymphoma Pipeline Therapeutics Assessment Report 2024 (Upda …

DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline

Go To Page:    31 32 33 34 35 36 37 38 39 40